4//SEC Filing
EnteroMedics Inc 4
Accession 0001209191-16-118172
CIK 0001371217operating
Filed
May 5, 8:00 PM ET
Accepted
May 6, 5:23 PM ET
Size
22.9 KB
Accession
0001209191-16-118172
Insider Transaction Report
Form 4
EnteroMedics IncETRM
TETI NICHOLAS
Director
Transactions
- Award
Director Option (Right to Buy)
2016-05-04+3,000→ 3,000 totalExercise: $0.75From: 2016-05-04Exp: 2026-05-04→ Common Stock (3,000 underlying)
Holdings
- 723
Common Stock
- 305
Director Option (right to buy)
Exercise: $671.55From: 2007-04-27Exp: 2017-04-27→ Common Stock (305 underlying) - 111
Director Option (right to buy)
Exercise: $396.15From: 2008-05-06Exp: 2018-05-06→ Common Stock (111 underlying) - 111
Director Option (right to buy)
Exercise: $173.70From: 2009-05-05Exp: 2019-05-05→ Common Stock (111 underlying) - 1,666
Director Option (right to buy)
Exercise: $207.00From: 2009-05-28Exp: 2019-05-28→ Common Stock (1,666 underlying) - 833
Director Option (right to buy)
Exercise: $48.60From: 2010-02-10Exp: 2020-02-10→ Common Stock (833 underlying) - 111
Director Option (right to buy)
Exercise: $37.80From: 2010-05-06Exp: 2020-05-06→ Common Stock (111 underlying) - 666
Director Option (right to buy)
Exercise: $39.45From: 2011-05-05Exp: 2021-05-05→ Common Stock (666 underlying) - 666
Director Option (right to buy)
Exercise: $41.55From: 2012-05-09Exp: 2022-05-09→ Common Stock (666 underlying) - 666
Director Option (right to buy)
Exercise: $13.20From: 2013-05-08Exp: 2023-05-08→ Common Stock (666 underlying) - 1,666
Director Option (right to buy)
Exercise: $27.60From: 2014-05-07Exp: 2024-05-07→ Common Stock (1,666 underlying) - 1,666
Director Option (right to buy)
Exercise: $16.80From: 2015-05-06Exp: 2025-05-06→ Common Stock (1,666 underlying) - 1,666
Director Option (right to buy)
Exercise: $16.80From: 2015-06-06Exp: 2025-05-06→ Common Stock (1,666 underlying)
Footnotes (5)
- [F1]On January 6, 2016, EnteroMedics Inc. effected a 1-for-15 reverse stock split of its issued and outstanding shares of common stock, par value $0.01 per share, resulting in a proportional decrease in the total shares of common stock beneficially owned by the reporting person. all previously reported exercise prices, option grants and similar instruments convertible into common stock were proportionally adjusted to reflect the reverse split.
- [F2]Vests immediately as to 25% on date noted and thereafter in cumulative installments of 1/36th per month.
- [F3]Vests in cumulative installments of 1/36th per month beginning the date shown.
- [F4]277 shares vest immediately and the remaining 556 shares vest in cumulative installments of 1/36th per month beginning 3/10/2010.
- [F5]Vests in cumulative installments of 1/12th per month beginning the date shown.
Documents
Issuer
EnteroMedics Inc
CIK 0001371217
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001371217
Filing Metadata
- Form type
- 4
- Filed
- May 5, 8:00 PM ET
- Accepted
- May 6, 5:23 PM ET
- Size
- 22.9 KB